Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (21-30 of 375) with videos related to

Pageof 38
Sort By:
Expert Review of Gastroenterology & Hepatology|November 29, 2014
Ramucirumab for gastric cancerKohei Shitara, Atsushi Ohtsu
Expert Review of Gastroenterology & Hepatology|January 11, 2020
Trifluridine/tipiracil for the treatment of metastatic gastric cancerAkihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[Cytotoxic Agents and Immune Checkpoint Inhibitors]Akihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Ⅲ.Current and Future Aspects of Precision Medicine for Esophageal and Gastric Cancer]Saori Mishima, Kohei Shitara
Expert Review of Anticancer Therapy|September 20, 2021
Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancerTakahiro Ishii, Kohei Shitara
Therapeutic Advances in Medical Oncology|January 21, 2021
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancerDaisuke Kotani, Kohei Shitara
JAMA Oncology|February 4, 2021
Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer-ReplyKohei Shitara, Josep Tabernero
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Molecular targeted therapy in colorectal cancer and its resistance]Kohei Shitara, Kei Muro
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
Advances in Systemic Therapy for Metastatic or Advanced Gastric CancerKohei Shitara, Atsushi Ohtsu
ESMO Open|August 25, 2020
Development of circulating tumour DNA analysis for gastrointestinal cancersYoshiaki Nakamura, Kohei Shitara
Pageof 38

Showing results (21-30 of 375) with videos related to

Sort By:
Pageof 38
Expert Review of Gastroenterology & Hepatology|November 29, 2014
Ramucirumab for gastric cancerKohei Shitara, Atsushi Ohtsu
Expert Review of Gastroenterology & Hepatology|January 11, 2020
Trifluridine/tipiracil for the treatment of metastatic gastric cancerAkihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[Cytotoxic Agents and Immune Checkpoint Inhibitors]Akihito Kawazoe, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Ⅲ.Current and Future Aspects of Precision Medicine for Esophageal and Gastric Cancer]Saori Mishima, Kohei Shitara
Expert Review of Anticancer Therapy|September 20, 2021
Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancerTakahiro Ishii, Kohei Shitara
Therapeutic Advances in Medical Oncology|January 21, 2021
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancerDaisuke Kotani, Kohei Shitara
JAMA Oncology|February 4, 2021
Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer-ReplyKohei Shitara, Josep Tabernero
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Molecular targeted therapy in colorectal cancer and its resistance]Kohei Shitara, Kei Muro
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
Advances in Systemic Therapy for Metastatic or Advanced Gastric CancerKohei Shitara, Atsushi Ohtsu
ESMO Open|August 25, 2020
Development of circulating tumour DNA analysis for gastrointestinal cancersYoshiaki Nakamura, Kohei Shitara
Pageof 38